from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2818c/-

LFCtreatmentdescriptionclass of inhibitor

0.049

Amikacinug/mL Amikacintranslation

-0.967

Cap5-10ug/mL Capreomycintranslation

-1.057

Rox10-50 ug/mL Roxithromycintranslation

-0.229

SM2-5 ug/mL Streptomycintranslation

-0.302

Tet5-10 ug/mL Tetracyclinetranslation

1.273

Rif0.2-5ug/mL Rifampicintranscription

-0.122

Rifp0.1-0.5ug/mL Rifapentinetranscription

2.621

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.073

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.242

CPZ10-50 ug/mL Chlorpromazinerespiration

0.340

Clofazimine10-13 ug/mL Clofaziminerespiration

0.461

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

2.475

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.781

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.002

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.086

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.161

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.227

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.154

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.072

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.493

KCN5-20 ug/mL Potassium cyaniderespiration

-0.340

NaN30.2-2 mM Sodium aziderespiration

-0.474

Nigericin50 uM Nigericinrespiration

0.122

TRC10-150 ug/mL Triclosanrespiration

0.579

TRZ10-25 ug/mL Thioridazinerespiration

-0.543

Valinomycin0.5-10 uM Valinomycinrespiration

-0.016

ZnSO42 mM ZnSO4respiration

0.408

menadione6-10 ug/mL Menadionerespiration

0.430

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.150

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.616

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.190

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.629

NRP_1Non-replicating persistence stage 1dosRassociated

-0.198

Amp0.2mg/mL AmpicillincellWall

-0.017

Cephalexin20-100 ug/mL CephalexincellWall

-0.067

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.195

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.140

EMB10-20 ug/mL EthambutolcellWall

0.762

Eta12-40 ug/mL EthionamidecellWall

-0.087

INH0.2-0.4 ug/mL IsoniazidcellWall

0.553

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.612

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.717

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.573

BZA0.12 mg/mL BenzamidearomaticAmides

0.243

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.255

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.027

H2O24 mM hydrogen peroxideDNAdamaging

0.385

Levo10 ug/mL LevofloxacinDNAdamaging

-0.855

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.795

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.430

Oflox5-10 ug/mL OfloxacinDNAdamaging

-1.476

UVUV-irradiationDNAdamaging

2.301

ARP41-4 ug/mL Antitubercular compound ARP4?

0.037

Antimycin12.5-50 ug/mL Antimycin A?

-0.100

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.132

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.682

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.910

PA8240.2-2 ug/mL PA-824?

0.710

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

1.310

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.297

Verapamil50 uM Verapamil?

0.601

mercaptoethanol2 mM 2-Mercaptoethanol?

0.622

methoxatin10-20 ug/mL Methoxatin?